Humanigen Inc (HGENQ)

[The Other Guy]

Good summary. I am confident despite the stock price.

Buyouts happen. Like you, I think Cameron is poised to go that route. Lenzilumab is proven and the proof strengthens daily if you consider the ongoing trials to have similar results as the P3. A larger biotech may be looking at Humanigen and saying, we can acquire them, put a turbo charger on Lenz trials and bring a BLA to the finish line.

For MHRA to be working as close with management as they are this late in the process is highly positive. Dialogue is a good sign. But I think the UK could consume 100k doses alone. Therefore $1 Billion revenue is accessible for 2022.

In summary, I think we are bound to get MHRA and we are bound to be acquired. But I think the price will be higher than you anticipate.